Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 31
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06306872 | A Clinical Trial to Evaluate the Relative Bioavailability of New and Old ABSK-011 Capsules | ||
| NCT05627063 | A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients With Advanced Solid Tumors | ||
| NCT05103917 | A Study to Assess the Safety, Tolerability and Antitumor Activity of X4P-001 in Combination With TNBC | ||
| NCT05804045 | Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER) | ||
| NCT06562946 | The Study to Assess the Pharmacokinetics of Pimicotinib in Subjects With Mild and Moderate Hepatic Impairment Relative to Subjects With Normal Hepatic Function | ||
| NCT06668103 | A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib | ||
| NCT05533788 | ABSK091 Food Effect Study in Healthy Subjects | ||
| NCT04906434 | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor | ||
| NCT07007546 | A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABSK061 Mini-tablets in Healthy Adult Participants | ||
| NCT06111274 | A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer | ||
| NCT07126249 | A Study to Evaluate the the Bioequivalence of Two Different Pimicotinib Capsules in Healthy Subjects | ||
| NCT07010497 | A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular Carcinoma | ||
| NCT05244551 | A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors | ||
| NCT07210996 | A Study to Evaluate the Relative Bioavailability of Pimicotinib Capsules Containing Free Base in Different Proportions in Healthy Subjects | ||
| NCT06779253 | A Study to Investigate The Effect of Pimicotinib on The Pharmacokinetics of Metformin, Fexofenadine and Rosuvastatin In Healthy Subjects | ||
| NCT06225804 | A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung Cancer | ||
| NCT05441475 | A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab in HCC Patients | ||
| NCT06694948 | A Study to Evaluate the Relative Bioavailability of Two Different Pimicotinib Capsules in Healthy Subjects | ||
| NCT04964375 | A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK043 in Patients With Advanced Solid Tumor | ||
| NCT06322706 | A Clinical Trial to Evaluate a High-Fat Meal and Omeprazole Enteric-coated Tablets on ASBK021 | ||
| NCT06186583 | A Mass Balance Study of [14C]ABSK021 | ||
| NCT06632262 | A Phase 2 Clinical Study of ABSK061 and ABSK043 | ||
| NCT07164170 | A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib | ||
| NCT06186804 | A Phase II Study Evaluating the Efficacy and Safety of ABSK021 (Pimicotinib)) in the Treatment of cGvHD Chronic Graft Versus Host Disease (cGvHD) | ||
| NCT05280483 | ABSK021 Food Effect Study in Healthy Subjects | ||
| NCT05086666 | A Phase 1b/2 Clinical Study to Evaluate the Safety and Tolerability and Efficacy of AZD4547 | ||
| NCT05775874 | A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC | ||
| NCT06884072 | A Study to Evaluate the Effect of a High-fat Meal on the Exposure of Pimicotinib Capsule in Healthy Subjects | ||
| NCT06089733 | A Clinical Trial to Evaluate the Effect of Itraconazole and Rifampicin on ABSK021 | ||
| NCT06896760 | A Mass Balance Study of [14C]ABSK011 | ||
| NCT04192344 | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor |
